Fund moves

Gilead Sciences (GILD)LBP Am SA added to its stake +127K shares

LBP Am SA added to its stake in Gilead Sciences, per its Q2 2026 13F.

265K
Shares reported · +127K vs prior quarter
0.34%
Disclosed portfolio weight
$33.5M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
  2. May 6, 2026Congress · 1 personMembers of Congress: 2 purchases
  3. Jun 1, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
  4. Jun 15, 2026Insider · 2 peopleInsiders: 4 sales (~$748K)
  5. Jun 24, 2026FDAFDA drug approval: Trodelvy
  6. Jun 24, 2026FDAFDA drug approval: Trodelvy
  7. Jul 1, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)
  8. Jul 15, 2026Insider · 2 peopleInsiders: 2 sales (~$780K)

What came next

  1. Aug 3, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
  2. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
  3. Aug 17, 2026Insider · 2 peopleInsiders: 3 sales (~$4.3M)
  4. Aug 20, 2026Insider · 1 personInsiders: 5 sales (~$725K)
  5. Aug 26, 2026Insider · 1 personInsiders: 4 sales (~$2.7M)
  6. Aug 27, 2026FDAFDA drug approval: Bixlenvo Sunlenca Starter Pack (Copackaged)
  7. Aug 27, 2026FDAFDA drug approval: Sunlenca
  8. Aug 27, 2026FDAFDA drug approval: Bixlenvo
  9. Aug 27, 2026FDAFDA drug approval: Sunlenca
  10. Sep 1, 2026Insider · 1 personInsiders: 3 sales (~$2.2M)
  11. Sep 15, 2026Insider · 2 peopleInsiders: 4 sales (~$869K)
  12. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$2.2M)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Gilead Sciences

For Gilead Sciences, OQRO holds 28 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 78 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.

How this filing works

Other disclosures at Gilead Sciences

Everything OQRO holds on this company is on its GILD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data